ADARX Revenue and Competitors
Estimated Revenue & Valuation
- ADARX's estimated annual revenue is currently $7.2M per year.
- ADARX's estimated revenue per employee is $219,273
Employee Data
- ADARX has 33 Employees.
- ADARX grew their employee count by 43% last year.
ADARX Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.2M | 6 | N/A | N/A | N/A |
#2 | N/A | 118 | 0% | $62.5M | N/A |
#3 | $138.3M | 688 | -4% | N/A | N/A |
#4 | $75.4M | 375 | N/A | N/A | N/A |
#5 | $63.9M | 318 | -8% | N/A | N/A |
#6 | $29.1M | 145 | N/A | N/A | N/A |
#7 | $892.7M | 2058 | 88% | $54.8M | N/A |
#8 | $1M | 9 | 80% | $37M | N/A |
#9 | $26.7M | 132 | 2% | $206.1M | N/A |
#10 | $56.7M | 65 | 81% | $60M | N/A |
What Is ADARX?
ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on base editing of mRNA transcripts. We discover and develop innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on a mRNA, thus the production of desired and functional protein is restored. Our mission is to discover and develop cutting-edge genetic therapeutics that precisely target and edit single point mutations on RNA transcripts to enable production of desired proteins. We are well-financed with backup from a group of renowned VC funds, and our brand-new laboratory is located in San Diego, California.
keywords:N/A
N/A
Total Funding
33
Number of Employees
$7.2M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in SAN DIEGO
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.6M | 33 | -11% | N/A |
#2 | $3.6M | 33 | 27% | N/A |
#3 | $7.1M | 33 | N/A | N/A |
#4 | $5.8M | 33 | N/A | N/A |
#5 | N/A | 33 | N/A | N/A |
